September 2, 2022 Ready to take off: Opportunities for developers and manufacturers in cell and gene therapy
Dr. Robert Panting, General Manager at Rentschler ATMP, recently spoke with transkript about the growing cell and gene therapy market and related opportunities for developers and manufacturers.
He addressed various topics, including current trends in the cell and gene therapy sector and the Rentschler ATMP offering in advanced therapies.
Read the full interview with Thomas Gabrielczyk to learn more about our team at Rentschler ATMP, UK, and our our soon-to-be-launched services for cell and gene therapies.
To read the full German article, click here.
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication